WINDTREE THERAPEUTICS INC /DE/ Amortization of Debt Issuance Costs and Discounts
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Amortization of Debt Issuance Costs and Discounts of $179.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $179.00K, a 588.46% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs and discounts for the quarter ending 2024-12-31 was $11.00K.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs and discounts for the quarter ending 2024-09-30 was $26.00K.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs and discounts for the quarter ending 2023-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs and discounts for fiscal 2024 was $97.00K.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs and discounts for fiscal 2023 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs and discounts for fiscal 2015 was $1.29M, a 33.93% decline from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs and discounts for fiscal 2014 was $1.95M, a 264.79% increase from fiscal 2013.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2025-09-30 | $179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $179.00K 10-Q · filed 2025-11-19 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-19 | |||
| 2024-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $37.00K derived: sum of 2 quarters · filed 2025-11-19 | $97.00K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $86.00K 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | $60.00K 10-Q · filed 2025-08-19 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-26 | $0.00 10-Q · filed 2024-11-26 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-19 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-12 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $138.00K derived: sum of 3 quarters · filed 2017-03-31 | $732.00K derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $138.00K derived: sum of 2 quarters · filed 2017-03-31 | $732.00K derived: sum of 3 quarters · filed 2017-03-31 | $1.29M 10-K · filed 2017-03-31 |
| 2015-09-30 | $138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $732.00K derived: sum of 2 quarters · filed 2016-11-14 | $1.29M 10-Q · filed 2016-11-14 | $1.82M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $594.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $1.15M 10-Q · filed 2016-08-10 | $1.68M derived: sum of 3 quarters · filed 2016-08-10 | $2.19M derived: sum of 4 quarters · filed 2016-08-10 |
| 2015-03-31 | $555.00K 10-Q · filed 2016-05-12 | $1.09M derived: sum of 2 quarters · filed 2016-05-12 | $1.59M derived: sum of 3 quarters · filed 2016-05-12 | $2.06M derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | $534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $1.04M derived: sum of 2 quarters · filed 2016-03-29 | $1.51M derived: sum of 3 quarters · filed 2016-03-29 | $1.95M 10-K · filed 2016-03-29 |
| 2014-09-30 | $505.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $975.00K derived: sum of 2 quarters · filed 2015-11-05 | $1.41M 10-Q · filed 2015-11-05 | $1.65M derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $470.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $909.00K 10-Q · filed 2015-08-10 | $1.14M derived: sum of 3 quarters · filed 2015-08-10 | $1.27M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $439.00K 10-Q · filed 2015-05-11 | $671.00K derived: sum of 2 quarters · filed 2015-05-11 | $796.00K derived: sum of 3 quarters · filed 2015-05-11 | $914.00K derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $357.00K derived: sum of 2 quarters · filed 2015-03-16 | $475.00K derived: sum of 3 quarters · filed 2015-03-16 | $534.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $243.00K derived: sum of 2 quarters · filed 2014-11-07 | $302.00K 10-Q · filed 2014-11-07 | $302.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $177.00K 10-Q · filed 2014-08-07 | $177.00K derived: sum of 3 quarters · filed 2015-03-16 | $177.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $59.00K 10-Q · filed 2014-05-12 | $59.00K derived: sum of 2 quarters · filed 2015-03-16 | $59.00K derived: sum of 3 quarters · filed 2015-03-16 | $59.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-07 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |